科瑞生物 (832780.oc)

+ 收藏

现金流量表(科瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 204,864,120.62107,265,760.44175,330,587.22124,817,578.47
 收到的税费返还(元) 8,602,066.23342,449.423,515,263.124,077,267.23
 收到其他与经营活动有关的现金(元) 2,866,074.82464,941.0816,232,927.793,035,713.13
 经营活动现金流入小计(元) 216,332,261.67108,073,150.94195,078,778.13131,930,558.83
 购买商品、接受劳务支付的现金(元) 77,530,219.2243,809,553.1468,518,707.4645,946,197.23
 支付给职工以及为职工支付的现金(元) 38,161,258.2715,200,788.9532,146,878.3315,386,485.62
 支付的各项税费(元) 20,120,558.9314,842,080.0310,153,379.553,934,499.45
 支付其他与经营活动有关的现金(元) 14,826,706.251,707,157.7022,687,910.1310,977,606.01
 经营活动现金流出小计(元) 150,638,742.6775,559,579.82133,506,875.4776,244,788.31
 经营活动产生的现金流量净额(元) 65,693,519.0031,121,414.3963,891,186.0055,685,770.52
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) 40,072.2340,072.23-16,889,504.15-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 115,705.45-242,193.00-
 收到其他与投资活动有关的现金(元) 10,000,000.0010,000,000.0010,000,000.00-
 投资活动现金流入小计(元) 10,155,777.6810,040,072.23-6,647,311.15-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 39,748,139.946,499,579.2717,260,738.6312,655,994.70
 投资支付的现金(元) --3,000,000.0053,000,000.00
 取得子公司及其他营业单位支付的现金净额(元) --48,805,904.85-
 支付其他与投资活动有关的现金(元) 10,000,000.0030,000,000.009,900,000.00-
 投资活动现金流出小计(元) 49,748,139.9436,499,579.2778,966,643.4865,655,994.70
 投资活动产生的现金流量净额(元) -39,592,362.26-26,459,507.04-85,613,954.63-65,655,994.70
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 89,000,000.0043,000,000.0048,600,000.0022,000,000.00
 收到其他与筹资活动有关的现金(元) 30,000,000.0030,000,000.0029,000,000.0029,000,000.00
 筹资活动现金流入小计(元) 119,000,000.0073,000,000.0077,600,000.0051,000,000.00
 偿还债务支付的现金(元) 65,900,000.0056,500,000.0026,825,210.9410,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 17,484,277.8515,532,836.771,880,887.05835,835.86
 支付其他与筹资活动有关的现金(元) 41,268,633.33293,103.2623,780,439.3418,959,925.96
 筹资活动现金流出小计(元) 124,652,911.1872,325,940.0352,486,537.3329,795,761.82
 筹资活动产生的现金流量净额(元) -5,652,911.18674,059.9725,113,462.6721,204,238.18
四、汇率变动对现金及现金等价物的影响(元) -287,393.70342,263.54803,914.48-
五、现金及现金等价物净增加额(元) 20,160,851.867,070,387.591,875,325.1811,234,014.00
 加:期初现金及现金等价物余额(元) 10,785,374.406,839,695.558,910,049.2211,111,396.87
 期末现金及现金等价物余额(元) 30,946,226.2613,910,083.1410,785,374.4022,345,410.87
补充资料:
 净利润(元) 71,076,485.8028,806,845.6060,465,104.1239,125,236.80
 资产减值准备(元) 12,952,517.57861,785.3312,043,248.21464,122.14
 固定资产和投资性房地产折旧(元) 10,468,655.096,239,681.108,556,560.733,786,560.88
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 10,468,655.096,239,681.108,556,560.733,786,560.88
 无形资产摊销(元) 944,042.18472,021.09734,600.62117,818.90
 长期待摊费用摊销(元) 1,535,693.13724,120.451,333,445.771,181,837.03
 处置固定资产、无形资产和其他长期资产的损失(元) 20,586.60138,293.28-133,266.72-
 固定资产报废损失(元) 656,243.732,972.829,482.511,866.60
 财务费用(元) 4,492,479.982,311,161.033,484,146.901,352,651.85
 投资损失(元) 119,503.11-2,938.422,587,899.98-75.00
 递延所得税(元) 3,114,362.00-1,530,617.02-3,570,494.022,980,651.65
  其中:递延所得税资产减少(元) 4,205,201.12-540,935.48-4,303,773.54114,777.36
 递延所得税负债增加(元) -1,090,839.12-989,681.54733,279.522,865,874.29
 存货的减少(元) 913,176.742,219,072.49-2,152,218.37-14,427,909.03
 经营性应收项目的减少(元) -32,702,780.403,310,985.98-25,150,214.728,978,654.42
 经营性应付项目的增加(元) -8,902,427.03-13,801,928.424,067,480.2711,577,000.66
 其他(元) -81,975.88---
 现金的期末余额(元) 30,946,226.2620,034,202.3010,785,374.4022,345,410.87
 减:现金的期初余额(元) 10,785,374.4010,785,374.408,910,049.2211,111,396.87
 现金及现金等价物的净增加额(元) 20,160,851.869,248,827.901,875,325.1811,234,014.00
公告日期 2024-04-192023-08-252023-03-312022-08-30
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院